dacetuzumab dacetuzumab dacetuzumab (also known as sgn-40 or hus2c6) is a humanized monoclonal antibody being developed for the treatment of cd40-positive cancers like non-hodgkin's lymphoma and hematological malignancies. dacetuzumabmonoclonal antibodytypewhole antibodysourcehumanized (from mouse)targetcd40clinical dataother namessgn-40atc codenoneidentifierscas number880486-59-9 nchemspidernoneuniiut59ff4t5xchemical and physical dataformulac6452h9964n1732o1998s42molar mass145111.33 g·mol−1 ny (what is this?) (verify) this drug was developed by seattle genetics, inc.